OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Legend Biotech Receives FDA IND Clearance for LB2501, a CD19/CD20 In Vivo CAR-T Therapy

Natalia Vilcu-Bajurean at LeukO 2026: A Mother's Powerful Promise to Change Childhood Cancer Care

Victor Moreno: Tumor Growth vs Antitumor Immunity, A New Strategy to Fight MSS Colorectal Cancer

"Stronger Regions, Stronger Countries..." - Dr Gevorg Tamamyan

Christopher Jackson: Humbled and Honoured to Receive the HRC’s Beaven Medal

Oncology News, Insights, Stories by OncoDaily

Rachna Shroff
Hall of Fame

Remembering Rachna Shroff: The Sunshine She Leaves Behind

metastatic breast cancer
Breast Oncology

ESMO 2026 Metastatic Breast Cancer Guideline: Biomarker-Driven Therapy Reshapes Treatment Across Subtypes

urothelial carcinoma
Genitourinary Oncology

What Comes Next? Treatment Sequencing in Advanced Urothelial Carcinoma

Parker Institute Investigators’ Startups Azalea and Medici Named to 2026 Endpoints 11

Daraxonrasib Receives Positive CHMP Opinion for Previously Treated Metastatic Pancreatic Cancer

5 Pancreatic Cancer Trials to Watch at ESMO 2026

The True Strength of The UICC Lies with Its Members: C S Pramesh’s Vision for UICC

Hayley Jones: Connecting Cancer Prevention, Law and Health Equity at Cancer Council Australia

Applications Are Now Open for Further Educational Grants 2027 - ESO

Andre Esteva։ ArteraAI Tests Recommended for Post-Prostatectomy Patients in Updated NCCN Guidelines

Voices
Emad Shash

Emad Shash: A Meaningful Conversation on the Breast Cancer Journey, From Diagnosis to Survivorship

Diane M. Simeone։ Breast Cancer Survivors Share How They Found Support and Community at Moores Cancer Center

Fumiko Ladd Chino։ Attending the First Session on Financial Toxicity Interventions at ASCOQLTY26

Florian Scotté։ The AFSOS and National League Against Cancer Sign Agreement to Improve Quality of Cancer Care

Bishal Gyawali on a Long-Awaited Meeting with Professor Mitsudomi at ASCO IAC

Pramesh CS: A Great Opportunity for Patients and Caregivers to Shape Healthcare and Research

“I’ll Carry Rachna’s Courage and Light With Me Always” - Aparna Parikh Remembers Rachna Shroff

FDA Approvals
CLL/SLL Pirtobrutinib

FDA Approves Pirtobrutinib for First-Line CLL/SLL Without 17p Deletion, a First for Non-Covalent BTK Inhibitors

Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications

Niklas Klümper: FDA Approves Belzutifan Plus Lenvatinib in Advanced ccRCC

FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated Advanced Breast Cancer

FDA Approves Taletrectinib Label Update With 49.7-Month Duration of Response in ROS1+ NSCLC

FDA Approves Curium’s Bexlutry (Lutetium Lu 177) for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

FDA Approves Floretyrosine F 18 for PET Imaging in Glioma

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Celebrities and Cancer

OncoCalendar

ASCO Quality Care Symposium 2026

American Society of Clinical Oncology

16 Oct
ASCO

16th Biennial Rivkin Ovarian Cancer Research Symposium

Ovarian Cancer Research Alliance

16 Oct
Ovarian Cancer Research Symposium

OPN Southwest Chapter Conference 2026

Oncology Pharmacy Network

17 Oct
OPN Southwest Chapter Conference

2026 WAHO and WON Advancing Oncology Together

Wisconsin Association of Hematology and Oncology (WAHO)

17 Oct
Advancing Oncology Together

19th AACR Conference on The Science of Cancer Health Disparities

American Association for Cancer Research

18 Oct
Cancer Health Disparities

Cytokines 2026: 14th Annual Meeting of The Cytokine Society

The Cytokine Society

18 Oct
Cytokines 2026

ESTRO - Evidence Based Radiation Oncology

European Society for Radiotherapy and Oncology (ESTRO)

19 Oct
Radiation Oncology

Rhabdomyosarcoma 2026: Advancing Science, Improving Outcomes

Memorial Sloan Kettering Cancer Center (MSK)

19 Oct
Rhabdomyosarcoma

VIDAWASI International Medical Congress 2026

VIDAWASI PERÚ

20 Oct
VIDAWASI

Kidney Week 2026

American Society of Nephrology (ASN)

21 Oct
Kidney Week 2026

Immune-oncology
KEYNOTE-966: Does Pembrolizumab Make Responses More Durable in Biliary Tract Cancer?

KEYNOTE-966: Does Pembrolizumab Make Responses More Durable in Biliary Tract Cancer?

Can Distant Lymph Nodes Sustain Immunotherapy After Lymph-Node Surgery?

BioNTech Shares Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy in Metastatic HPV16-Positive HNC

DECIDE-MET Trial: Targeted Therapy or Immunotherapy First in METex14 NSCLC?

KEYNOTE-B49 at ESMO 2026: Can Immunotherapy Find a Role in HR+/HER2− Breast Cancer?

INMC Analysis: Can Pathological Response Guide Treatment in Melanoma?

Nivolumab/Ipilimumab and Pembrolizumab for All Cancers: Australia Expands Immunotherapy Access

Gastrointestinal-Oncology
Daraxonrasib

Daraxonrasib Receives Positive CHMP Opinion for Previously Treated Metastatic Pancreatic Cancer

5 Pancreatic Cancer Trials to Watch at ESMO 2026

FFCD-AC: 1L Chemotherapy for Metastatic Recurrence of Ampullary Adenocarcinoma

Phase 3b SIERRA: Durvalumab Plus Tremelimumab in Poor-Prognosis Unresectable HCC

Phase 1b/2 HERBOT Trial: First-Line HER2-Targeted Chemoimmunotherapy in Biliary Tract Cancer

10 Must-Read Posts In GI Oncology This Week

9 Hepatobiliary Cancer Trials to Watch at ESMO 2026

Breast-Oncology
metastatic breast cancer

ESMO 2026 Metastatic Breast Cancer Guideline: Biomarker-Driven Therapy Reshapes Treatment Across Subtypes

MAMMÔ 2026: Precision, De-Escalation and New Treatment Sequencing Reshape Breast Cancer Care

Can Maintenance HER2 Therapy Be Stopped? Global Survey Reveals Clinical Equipoise in Long-Term Responders

NRG-BR002: Metastasis-Directed Ablation Fails to Improve PFS or OS in Oligometastatic Breast Cancer

Risk-Adapted Approach to Neoadjuvant Therapy in HER2-Positive Early Breast Cancer

How Systemic Therapy Is Reshaping Breast Cancer Care in 2026

HER2-Positive Breast Cancer in 2026: The New Goal Is Not More Treatment, but the Right Treatment

Lung-Oncology
LIGHT-NING

LIGHT-NING: Real-World Nivolumab Plus Ipilimumab Shows Durable Outcomes in Metastatic NSCLC

Jazz EMERGE 402: Real-World Lurbinectedin Shows Clinically Meaningful Activity in Previously Treated SCLC

AENEAS2: Aumolertinib Plus Chemotherapy Extends PFS in EGFR-Mutant Advanced NSCLC

Unresectable Stage III NSCLC: PACIFIC Remains the Backbone as Precision Strategies Reshape Care

Hong Kong Model Finds EGFR/ALK-First Testing More Cost-Efficient Than Upfront NGS in Metastatic NSCLC

Small-Molecule Inhibitors in NSCLC: A 2026 Practical Guide to Drug Interactions and Toxicity

AMAZE-lung Trial: Triple Targeting With Amivantamab, Lazertinib and Bevacizumab in EGFR-Mutant NSCLC

OncoDaily TV
Dr Gevorg Tamamyan

“Stronger Regions, Stronger Countries…” – Dr Gevorg Tamamyan

Rejin Kebudi

“Diligent, Intelligent, Capable of Reaching Many Colleagues Globally ” – Rejin Kebudi, General Secretary of the International Society of Pediatric Oncology, about Dr Gevorg Tamamyan Upon His WHO DG Candidacy

Dr. Gevorg Tamamyan

“One of the Most Amazing and Truly Legendary Oncologists of Our Time” – Dr. Gevorg Tamamyan on Dr. Julie Gralow, Chief Medical Officer of ASCO

Dr Gevorg Tamamyan

“I Still Remember His Mentees That Spoke So Highly of Him… Having a Vision Means Investing in People That Will Make a Difference For the Years to Come” – Albanian Hematologist Liri Seraj Supports Dr Gevorg Tamamyan as WHO DG Candidate

World Radiotherapy Awareness Day

12 Countries, One Vision for the Future of Radiotherapy – World Radiotherapy Awareness Day

Bishal Gyawali

Erika Ruiz-Garcia Joins Bishal Gyawali on Grounded In Groundshot Podcast

Dr Gevorg Tamamyan

“One Planet is Not Enough For His Vision” – Dr Amalya Sargsyan Celebrates Her Mentor Dr Gevorg Tamamyan

Dr Gevorg Tamamyan

Renowned Surgeon and Inventor of Abraxane, Philanthropist Dr Patrick Soon-Shiong Endorses Dr Gevorg Tamamyan as WHO Director-General Candidate

Burnout

Oncology Beyond Guidelines: Burnout, Imposter Syndrome, Mentorship & Cancer Prevention with Imène Hadji

Holistic Healing

Cancer Survivorship, Holistic Healing and Patient Advocacy with Rohini Singh Sisodia

ONCOFFEE

ONCOFFEE: Cancer Care in Nepal, Global Oncology, and Bridging Resource Gaps with Vivek Ghosh

The CML Evolution

The CML Evolution: Mastering Modern Algorithms in Chronic Myeloid Leukemia

Not To Miss
Parker Institute

Parker Institute Investigators’ Startups Azalea and Medici Named to 2026 Endpoints 11

Breast Health Day 2026: Why Early Detection Matters and Why Screening Cannot Wait

Legend Biotech Receives FDA IND Clearance for LB2501, a CD19/CD20 In Vivo CAR-T Therapy

Merck at ESMO 2026: Phase 3 mRNA, TROP2 ADC and Pembrolizumab Data Lead 90+ Abstracts

RYZ101 Improves PFS in Phase 3 ACTION-1 Trial for GEP-NETs After Lutetium-177 Therapy

15 Posts Not To Miss From DCLung26

Over 30,000 People Join Breast Care International Walk for Greater Rural Breast Cancer Awareness in Ghana

OncoGrants
KI–Mayo Clinic

Cancer Research KI–Mayo Clinic CCC Synergy Grants 2027–2031

Clinical Innovator Grant

CRI Clinical Innovator Grant 2026–2027

Clinical Unit Visit Fellowship

International Cancer Foundation Clinical Unit Visit Fellowship 2027–2028

Breast Cancer Alliance

Breast Cancer Alliance Breast Surgical Oncology Fellowship 2027

Scholar-in-Training Awards

AACR Global Scholar-in-Training Awards 2027: Global Cancer Research Support for Early-Career Scientists

Breast Cancer

FY26 Breast Cancer Research Program Breakthrough Award: Levels 1 and 2

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: Current Practice and Evolving Directions

CancerWorld

Oncologists
Alessandro Russo

Alessandro Russo

Oncologists Location Milan, Italy
Joyce Kambugu

Joyce Kambugu

Oncologists Location Kampala, Uganda
Maria T. Bourlon, MD, MSc, FASCO

María Teresa Bourlon

Oncologists Location Mexico City, Mexico
Sara Lonardi

Sara Lonardi

Oncologists Location Padua, Italy
Gilberto Lopes

Gilberto Lopes

Oncologists Location Miami, USA
Petros Grivas

Petros Grivas

Oncologists Location Seattle, USA
Vincenza Conteduca

Vincenza Conteduca

Oncologists Location Foggia, Italy
Layth Mula-Hussain

Layth Mula-Hussain

Oncologists Location Prince George, Canada

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Kefah Mokbel

Kefah Mokbel: Your Genes Are Not Your Destiny - Lifestyle Matters in Breast Cancer Prevention!

Premal Patel

Premal Patel: Beyond Biomarkers, Elephas Platform Predicts Immunotherapy Response Using Live Patient Tumor Tissue

Matthew Oser

Matthew Oser: The Mechanism Regulating ASCL1 Degradation in Small Cell Lung Cancer

Tiago Cordeiro Felismino

Tiago Cordeiro Felismino on Zanidatamab-Based Therapy in HER2-Positive Gastroesophageal Cancer

Lana Kandalaft

Lana Kandalaft: Transforming Therapeutic Cancer Vaccine Strategies for Pancreatic Cancer

American Cancer Society Journals

American Cancer Society Journals Highlights Personalized Physical Activity for Young Cancer Survivors

OncoDaily Medical Journal

Breast Cancer

10.69690/ODMJ-001-1026-8231

Variable-Volume Oncoplastic Reconstruction Using a Modified Würinger Central Pedicle Technique for Upper Quadrants Breast Cancer: a single-center experience
Original Research

GI Oncology

10.69690/ODMJ-001-1026-8138

Association of Alpha-Fetoprotein and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Camrelizumab Plus Rivoceranib vs Sorafenib: Post Hoc Exploratory Analysis of the CARES-310 Trial
Original Research

Oncology Nursing

10.69690/ODMJ-002-0926-8087

Risk of Atrial Fibrillation in Breast Cancer Patients Treated with Radiotherapy: A Scoping Review
Reviews

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts